Literature DB >> 1845173

A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics.

E R Gritz1, C R Carr, D A Rapkin, C Chang, J Beumer, P H Ward.   

Abstract

This paper describes the aims, study design, and patient accrual and characteristics from an ongoing randomized controlled trial evaluating a surgeon- and dentist-delivered smoking cessation intervention for head and neck cancer patients. Subjects (n = 186) accrued into the trial are profiled in terms of demographics, medical and treatment descriptors, smoking history and behavior at enrollment, and related psychosocial variables (mood, adherence indicators, and alcohol consumption). These patients have long histories of tobacco use, moderate to high levels of nicotine dependence, and a lack of overt mood disturbance and are receptive to behavioral change.

Entities:  

Mesh:

Year:  1991        PMID: 1845173

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  Prevalence and correlates of tobacco use among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia.

Authors:  Robert A Schnoll; Paul F Engstrom; Somasundaram Subramanian; Lev Demidov; Dustin B Wielt; Mourad Tighiouart
Journal:  Int J Behav Med       Date:  2006

2.  p16 (CDKN2A) SNP rs11515 was not associated with head and neck carcinoma.

Authors:  Ugo Borges Pinheiro; Carlos Alberto de Carvalho Fraga; Danilo Cangussu Mendes; Luciano Marques-Silva; Lucyana Conceição Farias; Marcela Gonçalves de Souza; Mariana Batista Soares; Kimberly Marie Jones; Sérgio Henrique Souza Santos; Alfredo Maurício Batista de Paula; Gustavo Velásquez-Meléndez; André Luiz Guimarães
Journal:  Tumour Biol       Date:  2014-03-15

3.  Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer.

Authors:  Sonia A Duffy; Angela L Scheumann; Karen E Fowler; Cynthia Darling-Fisher; Jeffrey E Terrell
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

4.  Evaluation of a Dedicated Tobacco Cessation Support Service for Thoracic Cancer Center Patients.

Authors:  Katharine A Amato; Mary E Reid; Heather M Ochs-Balcom; Gary A Giovino; Maansi Bansal-Travers; Graham W Warren; Martin C Mahoney; Andrew J Hyland
Journal:  J Public Health Manag Pract       Date:  2018 Sep/Oct

5.  Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey.

Authors:  Ulrike Schiller; Johanna Inhestern; Ulrike Burger; Susanne Singer; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-13       Impact factor: 2.503

6.  The influence of quality of life and depressed mood on smoking cessation among medically ill smokers.

Authors:  Rashelle B Hayes; Shira Dunsiger; Belinda Borrelli
Journal:  J Behav Med       Date:  2010-03-04

Review 7.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

Review 8.  Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.

Authors:  Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

9.  Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients.

Authors:  Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

10.  Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial.

Authors:  Diana B Díaz; Thomas H Brandon; Steven K Sutton; Lauren R Meltzer; Hannah J Hoehn; Cathy D Meade; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Hui-Yi Lin; Vani N Simmons
Journal:  Contemp Clin Trials       Date:  2016-07-25       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.